NICHD Global Network for Women’s and Children’s Health Research: Research Units
NICHD 全球妇女和儿童健康研究网络:研究单位
基本信息
- 批准号:10746195
- 负责人:
- 金额:$ 53.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-10 至 2030-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAdoptionAnemiaAzithromycinBacteriuriaBangladeshBirthBudgetsCOVID-19Cellular PhoneChildChild DevelopmentChild HealthChildbirthChildhoodClinical ProtocolsClinical ResearchClinical Research ProtocolsClinical TrialsClinical Trials DesignClinical Trials NetworkCommunicable DiseasesCommunitiesConduct Clinical TrialsCountryDevelopmentDiarrheaEnrollmentEnvironmentEquipmentEquityEthical ReviewEthicsFertilityGenderGoalsGovernmentGrantHealthHealth care facilityHospitalsHuman GeneticsHuman ResourcesHuman RightsImmunologyImpairmentIncomeInfantInfant MalnutritionInservice TrainingInternationalKineticsLaboratoriesLactationLeadershipLow Birth Weight InfantMainstreamingMaternal MortalityMaternal and Child HealthMaternal-fetal medicineModelingMothersNational Institute of Child Health and Human DevelopmentNeonatal MortalityNeonatologyNeurocognitiveOccupational activity of managing financesOralOutcomeOutcome StudyPaperPharmacodynamicsPharmacologyPoliciesPopulationPregnancyPregnant WomenPrincipal InvestigatorProtocols documentationPublicationsPublishingRecording of previous eventsRegistriesRehydration SolutionsReproductive HealthResearchResearch PersonnelReservationsRespiratory Tract InfectionsRoleRuralRural PopulationSARS-CoV-2 infectionScienceScientistSepsisServicesSiteStructureTrainingTranslationsUnderrepresented MinorityUniversitiesUrban PopulationVirginiaVisitWomanclinical research sitecommunity based caredata centersdata communicationdesigndietary supplementselectronic dataequity, diversity, and inclusionexperiencefollow-upgender-based violenceglobal healthhealth of the motherimplementation scienceimprovedinnovationinventionlaboratory facilitymultidisciplinaryneonatal healthneurodevelopmentnovelnutritionpediatric pharmacologypreventrecruitvaccine failurevaccinology
项目摘要
PROJECT SUMMARY
Significance: Mothers and children in Bangladesh and other low-mid income countries suffer disproportionately
from maternal and infant malnutrition, neonatal mortality from diarrhea and respiratory infections, and maternal
mortality from childbirth, vaccine failure and impaired child development. The UVA-icddrb Research Unit (RU)
addresses critical needs of women and young children by bringing to the Network strengths in infectious
diseases, lactation, pharmacology, neurocognitive development, human genetics, maternal-fetal medicine,
immunology, vaccinology and CTSA coordination. The RU has access to nearly 8000 pregnant women
annually at our existing clinical trial sites, is highly attuned to ethical and cultural issues with local community
and ethical review boards, and leads Network studies of COVID-19 in pregnancy and maternal anemia.
Investigators: The RU Principal Investigator (PI) William Petri and Senior Foreign Investigator (SFI) Rashidul
Haque have for 30 years co-led multidisciplinary teams studying maternal-child health, with over 170 co-
publications and ten on-going or completed clinical studies in the last five years. They are joined at icddr,b and
UVA by a diverse and multidisciplinary core team of 19 accomplished investigators in maternal-child health.
Innovation: The RU conceptualized the multi-site study of COVID-19 infection during pregnancy that
demonstrated minimal impact on birth outcomes, is leading a study of the role of maternal anemia on low-birth
weight infants, has multi-site Network-approved protocols on maternal nutritional supplements and on
asymptomatic bacteriuria and has pioneered electronic data capture for the Network. Special capabilities
include infectious diseases, pharmacology, lactation, and novel clinical trial designs through the CTSA.
Approach: The RU has conducted 12 clinical trials since 2016 with 99% adherence to follow-up visits, and
access to 8000 pregnant women annually in existing clinical trial sites. Science to policy translation catalyzed
by the partnership of the icddr,b with the Government of Bangladesh, as evidenced by the worldwide
implementation of oral rehydration solution, discovered at icddr,b and adoption nationwide, and the Matlab
model of community -based care.
Environment: The RU has unparalleled multidisciplinary strength, laboratory facilities and access to urban
and rural populations of mothers and children. The icddr,b is one of the foremost global health institutes in
the developing world with over 200 active clinical trials/protocols. The UVa Division of Infectious Diseases
and International Health has a unique focus on Global Health, with over $16 million in annual grant support and
over two dozen active clinical protocols. UVa-icddrb unique and complementary expertise will continue to bring
unparalleled strengths to the Network’s goal of making sustainable improvements in maternal and child health.
项目概要
意义:孟加拉国和其他中低收入国家的母亲和儿童遭受的苦难尤为严重
孕产妇和婴儿营养不良、腹泻和呼吸道感染导致的新生儿死亡以及孕产妇
分娩、疫苗失败和儿童发育受损导致的死亡率 UVA-icddrb 研究单位 (RU)
通过利用网络在传染病方面的优势,关键解决了妇女和幼儿的需求
疾病、哺乳、药理学、神经认知发育、人类遗传学、母胎医学、
RU 可以接触到近 8000 名孕妇。
每年在我们现有的临床试验地点进行一次,高度关注当地社区的道德和文化问题
和伦理审查委员会,并领导了 COVID-19 在妊娠和孕产妇贫血中的网络研究。
调查人员:RU 首席调查员 (PI) William Petri 和高级外国调查员 (SFI) Rashidul
Haque 30 年来共同领导了研究母婴健康的多学科团队,该团队有超过 170 名共同研究人员。
过去五年中发表的出版物和十项正在进行或已完成的临床研究它们在 icddr、b 和 中加入。
UVA 由多元化、多学科的核心团队组成,该团队由 19 名母婴健康方面卓有成效的研究人员组成。
创新:RU 构思了妊娠期间 COVID-19 感染的多中心研究,
对出生结果的影响极小,正在领导一项研究,证明孕产妇贫血对低产的影响
体重婴儿,拥有多站点网络批准的关于孕产妇营养补充剂和
无症状菌尿并开创了网络电子数据采集的特殊功能。
包括传染病、药理学、哺乳以及通过 CTSA 进行的新颖临床试验设计。
方法:RU 自 2016 年以来已开展 12 项临床试验,随访依从率为 99%,并且
每年在现有的临床试验地点接触 8000 名孕妇,促进科学到政策的转化。
正如世界范围内的情况所证明的那样,ICDDR,b 与孟加拉国政府建立了伙伴关系
口服补液溶液的实施,由 icddr,b 发现并在全国范围内采用,以及 Matlab
以社区为基础的护理模式。
环境: RU 拥有无与伦比的多学科实力、实验室设施和通往城市的通道
icddr,b 是世界上最重要的全球卫生机构之一。
发展中国家拥有超过 200 项活跃的临床试验/方案 UVa 传染病部门。
国际卫生部门对全球卫生有着独特的关注,每年提供超过 1600 万美元的赠款支持和
超过二十个活跃的临床方案将继续带来 UVa-icddrb 独特且互补的专业知识。
该网络对可持续改善孕产妇和儿童健康的目标具有无与伦比的优势。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Systemic inflammation, enteropathogenic E. Coli, and micronutrient insufficiencies in the first trimester as possible predictors of preterm birth in rural Bangladesh: a prospective study.
孟加拉国农村地区妊娠早期的全身炎症、肠病性大肠杆菌和微量营养素缺乏可能是早产的预测因素:一项前瞻性研究。
- DOI:
- 发表时间:2024-01-24
- 期刊:
- 影响因子:0
- 作者:Gerety, Meghan K;Kim, Debora K;Carpenter, Rebecca M;Ma, Jennie Z;Chisholm, Christian;Taniuchi, Mami;Islam, Md Ohedul;Pholwat, Suporn;Platts;Siraj, Md Shahjahan;Billah, Sk Masum;Haque, Rashidul;Petri Jr, William A
- 通讯作者:Petri Jr, William A
Setting up a maternal and newborn registry applying electronic platform: an experience from the Bangladesh site of the global network for women's and children's health.
建立孕产妇和新生儿登记电子平台:全球妇幼健康网络孟加拉国站的经验
- DOI:
- 发表时间:2020-11-30
- 期刊:
- 影响因子:3.4
- 作者:Billah, Sk Masum;Haque, Rashidul;Chowdhury, Atique Iqbal;Siraj, Md Shahjahan;Rahman, Qazi Sadequr;Hossain, Tanvir;Alam, Asraful;Alam, Masud;Marie, Chelsea;McGrath, Beth;El Arifeen, Shams;Petri Jr, William A
- 通讯作者:Petri Jr, William A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William A Petri其他文献
The impact of existing total anti-toxin B IgG immunity in outcomes of recurrent Clostridioides difficile infection.
现有总抗毒素 B IgG 免疫力对复发性艰难梭菌感染结果的影响。
- DOI:
10.1016/j.anaerobe.2024.102842 - 发表时间:
2024-03-01 - 期刊:
- 影响因子:2.3
- 作者:
Isaura Rigo;Mary K Young;Mayuresh M. Abhyankar;Feifan Xu;Girija Ramakrishnan;Farha Naz;William A Petri;Gregory R Madden - 通讯作者:
Gregory R Madden
Hyaluronan deposition during COVID-19 - helpful or harmful?
COVID-19 期间透明质酸沉积 - 有益还是有害?
- DOI:
10.1016/j.molmed.2024.01.003 - 发表时间:
2024-02-01 - 期刊:
- 影响因子:13.6
- 作者:
Duncan Hart;William A Petri - 通讯作者:
William A Petri
Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial
Dupilumab 治疗急性中度至重度 COVID-19 一年后的肺功能和生存率:IIa 期试验的后续研究
- DOI:
10.1101/2023.09.01.23293947 - 发表时间:
2023-09-02 - 期刊:
- 影响因子:0
- 作者:
Jennifer Hendrick;Jennie Z. Ma;H. Haughey;Rachael Coleman;Uma Nayak;A. Kadl;Jeffrey M. Sturek;Patrick E. H. Jackson;M. Young;Judi Allen;William A Petri - 通讯作者:
William A Petri
Quantifying the Impact of Natural Immunity on Rotavirus Vaccine Efficacy Estimates: A Clinical Trial in Dhaka, Bangladesh (PROVIDE) and a Simulation Study
量化自然免疫力对轮状病毒疫苗功效估计的影响:孟加拉国达卡的临床试验 (PROVIDE) 和模拟研究
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:6.4
- 作者:
Elizabeth T Rogawski;J. Platts;E. R. Colgate;R. Haque;K. Zaman;William A Petri;B. Kirkpatrick - 通讯作者:
B. Kirkpatrick
Genetic Susceptibility to Astrovirus Diarrhea in Bangladeshi Infants
孟加拉国婴儿星状病毒腹泻的遗传易感性
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Laura Chen;Rebecca M Munday;R. Haque;D. Duchen;Uma Nayak;P. Korpe;A. Mentzer;Beth D. Kirkpatrick;Genevieve L Wojcik;William A Petri;Priya Duggal - 通讯作者:
Priya Duggal
William A Petri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William A Petri', 18)}}的其他基金
Role of Th17 in Severe and Recurrent C. difficile Infection
Th17 在严重和复发性艰难梭菌感染中的作用
- 批准号:
10443698 - 财政年份:2020
- 资助金额:
$ 53.51万 - 项目类别:
Role of Th17 in Severe and Recurrent C. difficile Infection
Th17 在严重和复发性艰难梭菌感染中的作用
- 批准号:
10653065 - 财政年份:2020
- 资助金额:
$ 53.51万 - 项目类别:
Role of Th17 in Severe and Recurrent C. difficile Infection
Th17 在严重和复发性艰难梭菌感染中的作用
- 批准号:
10223165 - 财政年份:2020
- 资助金额:
$ 53.51万 - 项目类别:
University of Virginia - icddr,b Research Unit for Women's and Children's Health Research
弗吉尼亚大学 - icddr,b 妇女和儿童健康研究单位
- 批准号:
10413887 - 财政年份:2018
- 资助金额:
$ 53.51万 - 项目类别:
University of Virginia - icddr,b Research Unit for Women's and Children's Health Research
弗吉尼亚大学 - icddr,b 妇女和儿童健康研究单位
- 批准号:
10176548 - 财政年份:2018
- 资助金额:
$ 53.51万 - 项目类别:
University of Virginia - icddr,b Research Unit for Women's and Children's Health Research
弗吉尼亚大学 - icddr,b 妇女和儿童健康研究单位
- 批准号:
9754231 - 财政年份:2018
- 资助金额:
$ 53.51万 - 项目类别:
Role of Type 2 Immunity in Innate Protection from C. difficile
2 型免疫在艰难梭菌先天保护中的作用
- 批准号:
10467414 - 财政年份:2016
- 资助金额:
$ 53.51万 - 项目类别:
Role of Type 2 Immunity in Innate Protection from C. difficile
2 型免疫在艰难梭菌先天保护中的作用
- 批准号:
10561651 - 财政年份:2016
- 资助金额:
$ 53.51万 - 项目类别:
Role of IL-23 in the Immunopathogenesis of C. difficile colitis
IL-23 在艰难梭菌结肠炎免疫发病机制中的作用
- 批准号:
9057951 - 财政年份:2015
- 资助金额:
$ 53.51万 - 项目类别:
相似国自然基金
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
- 批准号:72304279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
- 批准号:82373638
- 批准年份:2023
- 资助金额:59 万元
- 项目类别:面上项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
- 批准号:72304180
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
- 批准号:82304256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于健康行为程式模型提升高血压患者药物依从性的干预策略构建研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Adapting Online Obesity Treatment for Primary Care Patients in Poverty
为贫困初级保健患者采用在线肥胖治疗
- 批准号:
10722366 - 财政年份:2023
- 资助金额:
$ 53.51万 - 项目类别:
Promoting Viral Suppression through the CHAMPS+ Intervention in the Deep South
通过 CHAMPS 干预南部腹地促进病毒抑制
- 批准号:
10819823 - 财政年份:2023
- 资助金额:
$ 53.51万 - 项目类别:
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
- 批准号:
10824878 - 财政年份:2023
- 资助金额:
$ 53.51万 - 项目类别:
Implementation of collaborative care for depression in VA HIV clinics: Translating Initiatives for Depression into Effective Solutions (HITIDES)
在 VA HIV 诊所实施抑郁症协作护理:将抑郁症倡议转化为有效解决方案 (HITIDES)
- 批准号:
9837042 - 财政年份:2023
- 资助金额:
$ 53.51万 - 项目类别:
Adaptation of a Digital Health Intervention for Chronic Condition Related fatigue to the Latino population
针对拉丁裔人群慢性病相关疲劳的数字健康干预措施的适应
- 批准号:
10697435 - 财政年份:2023
- 资助金额:
$ 53.51万 - 项目类别: